Connect with us

The Online Technology

Sanofi, GlaxoSmithKline Ink Coronavirus Vaccine Deal With U.S. – The Wall Street Journal


News & Analysis

Sanofi, GlaxoSmithKline Ink Coronavirus Vaccine Deal With U.S. – The Wall Street Journal

The U.S. government will pay up to $2.1 billion to Sanofi SA and GlaxoSmithKline PLC to fund the development of a coronavirus vaccine and guarantee supply of 100 million doses, if proven safe and effective in clinical trials, the companies said Friday. Paris-based Sanofi is leading development of the vaccine, the companies said, and plans…

The U.S. government will pay up to $2.1 billion to Sanofi SA and GlaxoSmithKline PLC to fund the development of a coronavirus vaccine and guarantee supply of 100 million doses, if proven safe and effective in clinical trials, the companies said Friday.

Paris-based Sanofi is leading development of the vaccine, the companies said, and plans to start initial clinical trials in September and move into late-stage studies by the end of this year.

Real Life. Real News. Real Voices

Help us tell more of the stories that matter

Become a founding member

Subscribe to the newsletter news

We hate SPAM and promise to keep your email address safe

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

To Top